Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna L Forrest

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Leukemia|August 23, 2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trialRyan Yen, Sarah Grasedieck, Andrew Wu, et al.
Science Translational Medicine|July 19, 2019
Response to Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL<sup>+</sup> human leukemia"Damian Lai, Min Chen, Jiechuang Su, et al.
Science Translational Medicine|February 14, 2018
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL<sup>+</sup> human leukemiaDamian Lai, Min Chen, Jiechuang Su, et al.
Leukemia Research|September 19, 2018
Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor eraMary Lynn Savoie, Isabelle Bence-Bruckler, Lothar B Huebsch, et al.
Blood|April 24, 2014
The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cellsKatharina Rothe, Hanyang Lin, Kevin B L Lin, et al.
Cell Stem Cell|May 16, 2020
Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase InhibitorsKatharina Rothe, Artem Babaian, Naoto Nakamichi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2012
Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signalsYasser R Abou Mourad, Rahul Bhargava, Hélène Bruyère, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2004
Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21)Haytham Khoury, Bakul I Dalal, Stephen H Nantel, et al.
British Journal of Haematology|October 20, 2004
Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantationCynthia L Toze, Michael J Barnett, Joseph M Connors, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myelomaJohn Kuruvilla, John D Shepherd, Heather J Sutherland, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Leukemia|August 23, 2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trialRyan Yen, Sarah Grasedieck, Andrew Wu, et al.
Science Translational Medicine|July 19, 2019
Response to Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL<sup>+</sup> human leukemia"Damian Lai, Min Chen, Jiechuang Su, et al.
Science Translational Medicine|February 14, 2018
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL<sup>+</sup> human leukemiaDamian Lai, Min Chen, Jiechuang Su, et al.
Leukemia Research|September 19, 2018
Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor eraMary Lynn Savoie, Isabelle Bence-Bruckler, Lothar B Huebsch, et al.
Blood|April 24, 2014
The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cellsKatharina Rothe, Hanyang Lin, Kevin B L Lin, et al.
Cell Stem Cell|May 16, 2020
Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase InhibitorsKatharina Rothe, Artem Babaian, Naoto Nakamichi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2012
Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signalsYasser R Abou Mourad, Rahul Bhargava, Hélène Bruyère, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2004
Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21)Haytham Khoury, Bakul I Dalal, Stephen H Nantel, et al.
British Journal of Haematology|October 20, 2004
Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantationCynthia L Toze, Michael J Barnett, Joseph M Connors, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myelomaJohn Kuruvilla, John D Shepherd, Heather J Sutherland, et al.
Pageof 5